With the availability of a simple test to detect malaria and a therapy to treat it effectively, the disease should no longer be a major public health issue. In fact, rapid diagnostic tests (RDTs) and artemisinin-based combination therapies (ACTs) have revolutionized malaria treatment in poor areas of Africa and South Asia. However, a meta-study reveals undesirable effects that accompany the benefits. Leslie Roberts, a deputy news editor at Science Magazine, discusses the underlying issues, points out the needs, and cites medical experts. getAbstract recommends this article to anyone interested in public health issues.
In this summary, you will learn
- How rapid diagnostic tests (RDTs) and artemisinin-based combination therapies (ACTs) combat malaria,
- Why health workers in poor regions still undertreat malaria, and
- Why some patients receive drugs they don’t need, while others don’t get the medication they need.
About the Author
Leslie Roberts is a deputy news editor at Science Magazine where she supervises the biology writing team. Her recent articles focus on infectious diseases in poor countries.